EpiBiologics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$107M
- Investors
-
15
EpiBiologics General Information
Description
Developer of protein degradation therapeutics designed to address disease-causing proteins through targeted degradation. The company specializes in antibody-based targeted therapies against the membrane and extracellular proteins, leveraging a modular system of bifunctional binding agents with a diverse atlas of tissue-selective surface receptors, enabling researchers to manipulate cellular proteostasis for the treatment of the disease.
Contact Information
Website
www.epibiologics.comCorporate Office
- 1900 Alameda de las Pulgas
- Suite 250
- San Mateo, CA 94403
- United States
Corporate Office
- 1900 Alameda de las Pulgas
- Suite 250
- San Mateo, CA 94403
- United States
EpiBiologics Timeline
EpiBiologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 31-Oct-2025 | $107M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 20-Jul-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2022 | Completed | Startup |
EpiBiologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
EpiBiologics Comparisons
Industry
Financing
Details
EpiBiologics Competitors (85)
One of EpiBiologics’s 85 competitors is Exo Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exo Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | ||||
| BioTheryx | Venture Capital-Backed | San Diego, CA | ||||
| Arvinas | Formerly VC-backed | New Haven, CT | ||||
| Plexium | Venture Capital-Backed | San Diego, CA |
EpiBiologics Patents
EpiBiologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026090081-A1 | Modified ch1 heterodimeric proteins | Pending | 21-Oct-2024 | ||
| US-20260042851-A1 | Binding agents and uses thereof | Pending | 02-Jul-2024 | ||
| WO-2026011013-A1 | Binding agents and uses thereof | Pending | 02-Jul-2024 | ||
| AU-2024371022-A1 | Compositions and methods of use for binding agents | Pending | 31-Oct-2023 | ||
| EP-4801973-A1 | Compositions and methods of use for binding agents | Pending | 31-Oct-2023 | C07K16/2878 |
EpiBiologics Signals
EpiBiologics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aulis Capital | Venture Capital | Minority | ||
| Avego Management | PE/Buyout | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Roche Venture Fund | Corporate Venture Capital | Minority |
EpiBiologics FAQs
-
When was EpiBiologics founded?
EpiBiologics was founded in 2022.
-
Where is EpiBiologics headquartered?
EpiBiologics is headquartered in San Mateo, CA.
-
What is the size of EpiBiologics?
EpiBiologics has 43 total employees.
-
What industry is EpiBiologics in?
EpiBiologics’s primary industry is Drug Discovery.
-
Is EpiBiologics a private or public company?
EpiBiologics is a Private company.
-
What is the current valuation of EpiBiologics?
The current valuation of EpiBiologics is .
-
What is EpiBiologics’s current revenue?
The current revenue for EpiBiologics is .
-
How much funding has EpiBiologics raised over time?
EpiBiologics has raised $180M.
-
Who are EpiBiologics’s investors?
Aulis Capital, Avego Management, Johnson & Johnson JJDC, Novartis Venture Fund, and Roche Venture Fund are 5 of 15 investors who have invested in EpiBiologics.
-
Who are EpiBiologics’s competitors?
Exo Therapeutics, ImmunOs Therapeutics, BioTheryx, Arvinas, and Plexium are some of the 85 competitors of EpiBiologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process